Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
23/11/2011 | 22:10 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
23/11/2011 | 20:01 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
23/11/2011 | 07:39 | Dow Jones News | Roche Buys Shares In Tender Offer For Anadys Pharmaceuticals | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
16/11/2011 | 12:02 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
14/11/2011 | 22:55 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
08/11/2011 | 14:16 | Marketwired | Acquisition Spotlight Shines on Hepatitis C Drug Developers | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
07/11/2011 | 23:01 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
07/11/2011 | 22:05 | PR Newswire (US) | Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
04/11/2011 | 21:34 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
26/10/2011 | 14:16 | Marketwired | Positive Test Results and Acquisitions Drive Shares of Exelixis and Anadys Higher | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
26/10/2011 | 12:02 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
25/10/2011 | 23:08 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
25/10/2011 | 22:25 | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
24/10/2011 | 22:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
21/10/2011 | 16:53 | Business Wire | The Law Firm of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
20/10/2011 | 21:39 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
20/10/2011 | 12:08 | Dow Jones News | Roche MS Drug's Good Test Results Boost Pipeline's Prospects | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
20/10/2011 | 01:00 | Business Wire | Faruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
19/10/2011 | 23:14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
19/10/2011 | 19:12 | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Anadys Pharmaceuticals Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
19/10/2011 | 05:30 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
18/10/2011 | 15:00 | Marketwired | Analyst View, Impact of Global Events - Research Report on Anadys Pharmaceuticals, Inc. and Kinder Morgan Energy Partners LP | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
18/10/2011 | 02:32 | Business Wire | Robbins Umeda LLP Announces an Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
18/10/2011 | 01:37 | Business Wire | Ryan & Maniskas, LLP Announces Investigation of Anadys Pharmaceuticals Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
17/10/2011 | 20:42 | PR Newswire (US) | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys... | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
17/10/2011 | 19:48 | Business Wire | Tripp Levy PLLC Announces Investigation of Anadys Pharmaceuticals | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
17/10/2011 | 17:50 | Zacks | Roche Targets Anadys Pharma - Analyst Blog | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
17/10/2011 | 16:50 | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
17/10/2011 | 14:07 | PR Newswire (US) | Anadys Announces Agreement To Be Acquired By Roche | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
17/10/2011 | 07:49 | Dow Jones News | Roche To Acquire Anadys Pharmaceuticals, Inc. For $230 Million | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |